Compare · GBS vs LRCX
GBS vs LRCX
Side-by-side comparison of GBS Inc. (GBS) and Lam Research Corporation (LRCX): market cap, price performance, sector, and recent activity on the wire.
Summary
- GBS operates in Industrials, while LRCX operates in Technology - the two are in different parts of the market.
- LRCX is the larger of the two at $405.75B, about 30633.0x GBS ($13.2M).
- LRCX has hit the wire 4 times in the past 4 weeks while GBS has been quiet.
- LRCX has more recent analyst coverage (25 ratings vs 0 for GBS).
- Company
- GBS Inc.
- Lam Research Corporation
- Price
- $0.46-16.25%
- $324.22+6.91%
- Market cap
- $13.2M
- $405.75B
- 1M return
- -
- +13.17%
- 1Y return
- -
- +267.35%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- 1984
- News (4w)
- 0
- 4
- Recent ratings
- 0
- 25
GBS Inc.
GBS Inc. operates as a biosensor diagnostic technology company. Its principal product is Saliva Glucose Biosensor, a saliva glucose monitoring system for diabetes management. The company also focuses on developing other diagnostic tests in the areas of biochemistry, tumor markers, immunology, hormones, and other biomarkers. It has a research agreement with Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic tests. GBS Inc. was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was founded in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Lam Research Corporation
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products. It also provides SPEED gapfill high-density plasma chemical vapor deposition products; and Striker single-wafer atomic layer deposition products for dielectric film solutions. In addition, the company offers Flex for dielectric etch applications; Kiyo for conductor etch applications; Syndion for through-silicon via etch applications; and Versys metal products for metal etch processes. Further, it provides Coronus bevel clean products to enhance die yield; Da Vinci, DV-Prime, EOS, and SP series products to address various wafer cleaning applications; and Metryx mass metrology systems for high precision in-line mass measurement in semiconductor wafer manufacturing. The company sells its products and services to semiconductors industry in the United States, China, Europe, Japan, Korea, Southeast Asia, Taiwan, and internationally. Lam Research Corporation was incorporated in 1980 and is headquartered in Fremont, California.
Latest GBS
- SEC Form SC 13G/A filed by GBS Inc. (Amendment)
- SEC Form SC 13G/A filed by GBS Inc. (Amendment)
- SEC Form 8-K filed by GBS Inc.
- SEC Form 10-Q filed by GBS Inc.
- GBS Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits
- SEC Form SC 13G/A filed by GBS Inc. (Amendment)
- GBS Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- GBS Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- GBS Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
- SEC Form S-8 filed by GBS Inc.
Latest LRCX
- Senior Vice President Fernandes Neil J sold $2,371,226 worth of shares (7,659 units at $309.60) as part of a pre-agreed trading plan, decreasing direct ownership by 12% to 58,470 units (SEC Form 4)
- SEC Form SD filed by Lam Research Corporation
- Lam Research Corporation Declares Quarterly Dividend
- Lam Research upgraded by Morgan Stanley with a new price target
- SEC Form 144 filed by Lam Research Corporation
- Lam Research Corporation Announces Participation at Upcoming Conferences
- Seaport Research Partners initiated coverage on Lam Research with a new price target
- Senior Vice President Fernandes Neil J sold $4,635,894 worth of shares (18,170 units at $255.14) as part of a pre-agreed trading plan, decreasing direct ownership by 22% to 66,129 units (SEC Form 4)
- Chief Legal Officer Harter Ava sold $1,554,547 worth of shares (6,010 units at $258.66) and exercised 6,010 shares at a strike of $77.04 (SEC Form 4)
- SEC Form 10-Q filed by Lam Research Corporation